In replication analyses using independent prospective analysis of 977 incident colorectal cancer cases and 4080 non-cases in EPIC and 860 incident colorectal cancer cases and 50 177 controls in the UK Biobank, directly measured lower circulating ANGPTL4 concentrations were associated with reduced colorectal cancer risk. This evidence concerns the gene ANGPTL4 and colorectal cancer.